Table 4.

Association of body adiposity measures with hyperuricemia in female subjects.

	n	Events, n (%)	Model I		Model II		Model III
			P	OR (95%CI)	P	OR (95%CI)	P	OR (95%CI)
NECK CIRCUMFERENCE
Q1 (≤32.0)	1,639	94 (5.7)		Ref.		Ref.		Ref.
Q2 (32.1–34.0)	998	79 (7.9)	0.028	1.42 (1.04–1.93)	0.033	1.40 (1.03–1.91)	0.127	1.28 (0.93–1.75)
Q3 (34.1–35.0)	1,603	202 (12.6)	<0.001	2.37 (1.82–3.06)	<0.001	2.33 (1.81–3.01)	<0.001	1.99 (1.53–2.58)
Q4 (≥35.1)	1,362	276 (20.3)	<0.001	4.18 (3.27–5.35)	<0.001	4.07 (3.18–5.22)	<0.001	3.27 (2.53–4.22)
WAIST CIRCUMFERENCE
Q1 (≤76.9)	1,199	57 (4.7)		Ref.		Ref.		Ref.
Q2 (77.0–82.9)	1,317	112 (8.5)	<0.001	1.87 (1.34–2.59)	<0.001	1.84 (1.32–2.56)	0.004	1.63 (1.17–2.27)
Q3 (83.0–89.9)	1,621	196 (12.1)	<0.001	2.76 (2.04–3.75)	<0.001	2.63 (1.94–3.58)	<0.001	2.20 (1.61–3.01)
Q4 (≥90.0)	1,465	286 (19.5)	<0.001	4.87 (3.62–6.54)	<0.001	4.53 (3.37–6.11)	<0.001	3.50 (2.58–4.77)

OR, odd ratio; CI, confidence interval; Ref., reference. Model I, unadjusted; Model II, Model I+ adjusted for age, current smoking status and current drinking status Model III, Model II+ adjusted for Triglycerides, High-density lipoprotein, hypertension, diabetes, cardiovascular and cerebrovascular events.